http://www.tarheelhoopla.com/?p=94
Life sciences and technology investo rSafeguard (NYSE:SFE) said the gain and an increase in shareholders’ equity will be recognized in the currenyt quarter ending June 30. A privats placement with reduced Safeguard’z share in Clarient (NASDAQ:CLRT) from about 50 percenr to about47 percent. Safeguarcd President and CEO Peter J. Boni said the deal “no t only strengthened our balance sheet andfinanciak flexibility, but the value of Safeguard’s ongoingg stake in Clarient can now be more readilty understood by the investment community.” Safeguard said the markett value of its remaining holdings is abouft $123 million as of Wednesday.
Clarient providew anatomic pathology and molecular testing servicezsto pathologists, oncologists and the pharmaceutical industry. It’a based in Aliso Viejo, Calif.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment